[The effect of nalidixic acid on the course of experimental pyelonephritis under the influence of resistance-affecting drugs].
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003687:Dehydroepiandrosterone / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006386:Hemagglutination Tests; D006854:Hydrocortisone / Q000627:therapeutic use*; D007106:Immune Sera; D008297:Male; D009268:Nalidixic Acid / Q000627:therapeutic use*; D011422:Propionates / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D011817:Rabbits; D013739:Testosterone / Q000627:therapeutic use*
D000906:Antibodies; D007106:Immune Sera; D011422:Propionates; D009268:Nalidixic Acid; D013739:Testosterone; D003687:Dehydroepiandrosterone; D006854:Hydrocortisone
Die Wirkung von Nalidixinsäure auf den Ablauf der experimentellen Pyelonephritis unter dem Einfluss resistenzbeeinflussender Pharmaka.